Identification of ginkgolide targets in brain by photoaffinity labeling

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Chemical Biology and Drug Design

• Publication date

  2017-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/cbdd.12883PMID 27743504PMCID PMC5378617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The bowel and beyond: the enteric nervous system in neurological disorders

  2016cited by this paper
• Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Aβ25–35‐induced neurotoxicity in human neuroblastoma cells

  2015cited by this paper
• Ginkgolide B Protects Neurons from Ischemic Injury by Inhibiting the Expression of RTP801

  2015cited by this paper
• Regulation of microtubule motors by tubulin isotypes and posttranslational modifications

  2014cited by this paper
• Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

  2014cited by this paper
• Neuroprotection against permanent focal cerebral ischemia by ginkgolides A and B is associated with obstruction of the mitochondrial apoptotic pathway via inhibition of c‐Jun N‐terminal kinase in rats

  2014cited by this paper
• Ginkgo Biloba Extract and Long-Term Cognitive Decline: A 20-Year Follow-Up Population-Based Study

  2013cited by this paper
• Ginkgolide B preconditioning on astrocytes promotes neuronal survival in ischemic injury via up-regulating erythropoietin secretion.

  2013cited by this paper
• A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine

  2013cited by this paper
• Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.

  2012cited by this paper
• Formation and functions of asymmetric microtubule organization in polarized cells.

  2012cited by this paper
• Flavonoids as modulators of memory and learning: molecular interactions resulting in behavioural effects

  2012cited by this paper
• Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.

  2012cited by this paper
• Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®

  2012cited by this paper
• Probing proteomes with benzophenone photoprobes.

  2012cited by this paper
• Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton.

  2010cited by this paper
• The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex

  2010cited by this paper
• Effects of Ginkgo biloba in dementia: systematic review and meta-analysis

  2010cited by this paper
• Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.

  2010cited by this paper
• Microtubule-binding agents: a dynamic field of cancer therapeutics

  2010cited by this paper
• Tubulin tyrosination navigates the kinesin-1 motor domain to axons

  2009cited by this paper
• Beyond polymer polarity: how the cytoskeleton builds a polarized cell

  2008cited by this paper
• Ginkgo biloba for prevention of dementia: a randomized controlled trial.

  2008cited by this paper
• Synthesis of novel ginkgolide photoaffinity--biotin probes.

  2007cited by this paper
• EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease

  2007cited by this paper
• Semi-supervised learning for peptide identification from shotgun proteomics datasets

  2007cited by this paper
• Amyloid-β-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans

  2006cited by this paper
• A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

  2005cited by this paper
• Terpene trilactones from Gingko biloba: from ancient times to the 21st century.

  2005cited by this paper
• In vivo biodistribution of ginkgolide B, a constituent of Ginkgo biloba, visualized by MicroPET.

  2005cited by this paper
• Asymmetric cell division in C. elegans: cortical polarity and spindle positioning.

  2004cited by this paper
• Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability.

  2004cited by this paper
• Cortical control of microtubule stability and polarization.

  2004cited by this paper
• Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study.

  2003cited by this paper
• An anxiolytic-like effect of Ginkgo biloba extract and its constituent, ginkgolide-A, in mice.

  2003cited by this paper
• Regulation of microtubule‐organizing center orientation and actomyosin cytoskeleton rearrangement during immune interactions

  2002cited by this paper
• Cdc42, dynein, and dynactin regulate MTOC reorientation independent of Rho-regulated microtubule stabilization.

  2001cited by this paper
• Control of spindle polarity and orientation in Saccharomyces cerevisiae.

  2001cited by this paper
• The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands.

  2001cited by this paper
• The Ginkgo biloba extract EGB 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands

  2000cited by this paper
• The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloid

  2000cited by this paper
• The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid.

  2000cited by this paper
• Free radicals in Alzheimer's dementia: currently available therapeutic strategies.

  1998cited by this paper
• Depletion of lysophosphatidic acid triggers a loss of oriented detyrosinated microtubules in motile fibroblasts.

  1996cited by this paper
• Postpolymerization detyrosination of alpha-tubulin: a mechanism for subcellular differentiation of microtubules

  1987cited by this paper
• Microtubule assembly in the absence of added nucleotides.

  1973cited by this paper

• Computational Drug Repurposing for Alzheimer’s Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies

  2021cites this paper
• The enduring legacy of Koji Nakanishi's research on bioorganic chemistry and natural products. Part 1: Isolation, structure determination and mode of action.

  2020cites this paper
• The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review

  2019cites this paper